Literature DB >> 21286250

Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study.

Huan Yu1, Luc Laberge, Isabelle Jaussent, Sophie Bayard, Sabine Scholtz, Morales Raoul, Michel Pages, Yves Dauvilliers.   

Abstract

STUDY
OBJECTIVES: Excessive daytime sleepiness (EDS) and high daytime REM sleep pressure are important sleep features of myotonic dystrophy (DM1). Small and uncontrolled studies have focused on EDS phenotype; none have focused on nocturnal REM sleep characteristics in DM1. Our objectives were to compare polysomnographic and multiple sleep latency test (MSLT) parameters, and both tonic and phasic components of REM sleep between DM1 and controls. DESIGN AND PATIENTS: Forty consecutive DM1 patients and 40 sex- and age-matched controls were included. All subjects underwent overnight polysomnography followed by a MSLT.
RESULTS: About 80% of DM1 patients complained of EDS through clinical interview: 31.4% had Epworth scores > 10, and 12.5% had objective sleepiness (latency < 8 min). Higher apnea and central apnea indexes, and a greater proportion of subjects with severe apnea/hypopnea syndrome were found in DM1. The number of SOREMP differed between DM1 and controls, one and two SOREMPs being present in 47.5% and 32.5%, and one control had one SOREMP. Higher percentages of slow wave sleep and REM sleep were found in DM1. DM1 patients had significantly more PLMW, PLMS in both NREM and REM sleep, and PLMS-associated microarousals. Higher REM density was found in DM1 with similar tendencies for either REM sleep without atonia or phasic EMG activity.
CONCLUSIONS: This is the first case-control sleep study in DM1 to demonstrate higher frequency of daytime sleepiness and abnormalities in REM sleep regulation, with an increased daytime and nighttime REM sleep propensity, REM density, and PLMS. These data suggest a primary central sleep regulation dysfunction in DM1.

Entities:  

Keywords:  MSLT; Myotonic dystrophy; PLM; REM sleep; excessive daytime sleepiness

Mesh:

Year:  2011        PMID: 21286250      PMCID: PMC3022936          DOI: 10.1093/sleep/34.2.165

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  34 in total

1.  Respiratory and hemodynamic study during wakefulness and sleep in myotonic dystrophy.

Authors:  C Guilleminault; J Cummiskey; J Motta; P Lynne-Davies
Journal:  Sleep       Date:  1978-09       Impact factor: 5.849

Review 2.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

Authors:  Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

3.  Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy.

Authors:  John W Gibbs; Emma Ciafaloni; Rodney A Radtke
Journal:  Sleep       Date:  2002-09-15       Impact factor: 5.849

4.  Hypersomnia in dystrophia myotonica: a neurophysiological and immunogenetic study.

Authors:  R Manni; C Zucca; M Martinetti; A Ottolini; G Lanzi; A Tartara
Journal:  Acta Neurol Scand       Date:  1991-12       Impact factor: 3.209

5.  Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.

Authors:  Jose E Martínez-Rodríguez; Ling Lin; Alex Iranzo; David Genis; Maria J Martí; Joan Santamaria; Emmanuel Mignot
Journal:  Sleep       Date:  2003-05-01       Impact factor: 5.849

6.  CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.

Authors:  Y Dauvilliers; C R Baumann; B Carlander; M Bischof; T Blatter; M Lecendreux; F Maly; A Besset; J Touchon; M Billiard; M Tafti; C L Bassetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

7.  Sleep-related breathing impairment in myotonic dystrophy.

Authors:  F Cirignotta; S Mondini; M Zucconi; E Barrot-Cortes; C Sturani; M Schiavina; G Coccagna; E Lugaresi
Journal:  J Neurol       Date:  1987-12       Impact factor: 4.849

8.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

9.  REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease.

Authors:  J F Gagnon; M A Bédard; M L Fantini; D Petit; M Panisset; S Rompré; J Carrier; J Montplaisir
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

10.  Absence of sleep-related growth hormone elevations in myotonic dystrophy.

Authors:  A Culebras; S Podolsky; N A Leopold
Journal:  Neurology       Date:  1977-02       Impact factor: 9.910

View more
  23 in total

Review 1.  Daytime sleepiness and myotonic dystrophy.

Authors:  Luc Laberge; Cynthia Gagnon; Yves Dauvilliers
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

Review 2.  Myotonic dystrophy.

Authors:  Charles A Thornton
Journal:  Neurol Clin       Date:  2014-06-06       Impact factor: 3.806

Review 3.  Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2.

Authors:  Andrea Romigi; Michelangelo Maestri; Carmine Nicoletta; Giuseppe Vitrani; Marco Caccamo; Gabriele Siciliano; Enrica Bonanni; Diego Centonze; Alessandro Sanduzzi
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

Review 4.  [Sleep and neurological diseases].

Authors:  G Mayer
Journal:  Nervenarzt       Date:  2016-06       Impact factor: 1.214

Review 5.  Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.

Authors:  Zeeshan Khan; Lynn Marie Trotti
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

6.  Evaluation of CNS involvement in myotonic dystrophy type 1 and type 2 by transcranial sonography.

Authors:  Christos Krogias; Barbara Bellenberg; Christian Prehn; Ruth Schneider; Saskia H Meves; Ralf Gold; Carsten Lukas; Christiane Schneider-Gold
Journal:  J Neurol       Date:  2014-11-11       Impact factor: 4.849

7.  Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2.

Authors:  Maria Laura Ester Bianchi; Anna Losurdo; Chiara Di Blasi; Massimo Santoro; Marcella Masciullo; Giulia Conte; Venanzio Valenza; Antonello Damiani; Giacomo Della Marca; Gabriella Silvestri
Journal:  Sleep Breath       Date:  2013-12-06       Impact factor: 2.816

8.  Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2.

Authors:  Erek M Lam; Paul W Shepard; Erik K St Louis; Lucas G Dueffert; Nancy Slocumb; Stuart J McCarter; Michael H Silber; Bradley F Boeve; Eric J Olson; Virend K Somers; Margherita Milone
Journal:  Neurology       Date:  2013-06-07       Impact factor: 9.910

9.  Increased EEG Theta Spectral Power in Sleep in Myotonic Dystrophy Type 1.

Authors:  Joseph Cheung; Chad Ruoff; Hyatt Moore; Katharine A Hagerman; Jennifer Perez; Sarada Sakamuri; Simon C Warby; Emmanuel Mignot; John Day; Jacinda Sampson
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

10.  Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy.

Authors:  Konstantinos Charizanis; Kuang-Yung Lee; Ranjan Batra; Marianne Goodwin; Chaolin Zhang; Yuan Yuan; Lily Shiue; Melissa Cline; Marina M Scotti; Guangbin Xia; Ashok Kumar; Tetsuo Ashizawa; H Brent Clark; Takashi Kimura; Masanori P Takahashi; Harutoshi Fujimura; Kenji Jinnai; Hiroo Yoshikawa; Mário Gomes-Pereira; Geneviève Gourdon; Noriaki Sakai; Seiji Nishino; Thomas C Foster; Manuel Ares; Robert B Darnell; Maurice S Swanson
Journal:  Neuron       Date:  2012-08-09       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.